There are studies that reported DIABLO as overexpressed in GC, CRC, and ovarian cancer and as downregulated in PCa, lung, and soft tissue cancers, as well as in BC tissues, with its expression decreasing with BC progression [47]. The gene discussed is DIABLO; the disease is ovarian carcinoma.